Logo for NovoCure Limited

NovoCure Investor Relations Material

Latest events

Logo for NovoCure Limited

Q4 2023

NovoCure
Logo for NovoCure

Q4 2023

22 Feb, 2024
Logo for NovoCure

Q3 2023

26 Oct, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. It provides Tumor Treating Fields (TTFields), which are characterized by low-intensity, high-frequency oscillating electric fields that disrupt cell division. The company offers TTFields delivery systems to deliver low intensity alternating electric fields in combination with standard of care chemotherapy.